Selected References: Bowman, J. D., Kim, H., & Bustamante, J. J. 2012. Drug‐Induced gynecomastia. Pharmacotherapy the Journal of Human Pharmacology and Drug Therapy, 32(12), 1123–1140. Carone, L., Oxberry, S. G., Twycross, R., Charlesworth, S., Mihalyo, M., & Wilcock, A. 2016. Spironolactone. Journal of Pain and Symptom Management, 53(2), 288–292. de Arriba G, Sanchez-Heras M, Basterrechea MA. 2009. Gitelman syndrome during pregnancy: a therapeutic challenge. Arch Gynecol …
The Baby Blog
About Our Baby Blog
Every person wants to know what’s best for their baby, especially when it comes to knowing how to minimize exposure risks. Our relatable stories are packed with practical information from our rotating staff of MotherToBaby expert bloggers. Whatever topic you’re looking for, our blogs will provide you a great foundation to learn more.
Benzocaine
Selected References: Berkovitch M, et al. 2002. Sore throat treatment during pregnancy: a prospective, controlled, pilot study. Clin Drug Invest, 22(2):135-139. Lezhepekova YA et al. 2024. Methemoglobinemia in a child with congenital epidermolysis bullosa. Вестник анестезиологии и реаниматологии, 21(1): 95-99. Heinonen OP, et al. 1977. Birth Defects and Drugs in Pregnancy. Publ Sci Group, Inc, Littleton, MA, 357-365.. US Food and Drug Administration. 2018. Risk of serious and …
Miglustat (Zavesca®)
Selected References: Amory JK, et al. 2007. Miglustat has no apparent effect on spermatogenesis in normal men. Hum Reprod; 22(3):702-707. Bone W, et al. 2007. The sensitivity of murine spermiogenesis to miglustat is a quantitative trait: a pharmacogenetic study. Reprod Biol Endocrinol; 5:1. Granovsky-Grisaru, S et al. 2011. The management of pregnancy in Gaucher disease. Thromb Haemost, 156:3-8. Hollak, C et al. 2009. Miglustat (Zavesca®) in type I Gaucher disease: 5-year …
Functional Constipation
Selected References: Longstreth GF, et al. 2006. Functional bowel disorders. Gastroenterology, 130(5):1480-1491. Mearin F, et al. 2016. Bowel disorders. Gastroenterology, S0016-5085(16)00222-5. Shi W, et al. 2015. Epidemiology and risk factors of functional constipation in pregnant women. PLoS One, 10(7):e0133521. …
Perphenazine
Selected References: Auerbach JG, Hans SL, Marcus J, Maeir S. 1992. Maternal psychotropic medication and neonatal behavior. Neurotoxicol Teratol 14:399-406. Chan J, Alldredge BK, Baskin LS. 1991. Perphenazine-induced priapism. DICP 24:246-9 FDA https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/089683s024lbl.pdf FDA Drug Safety Communication. 2011. Antipsychotic drug labels updated on use during pregnancy and risk of abnormal muscle movements and withdrawal symptoms in …
